A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer
Clinical trial NCT01062620 · COMPLETED
Trial details
- NCT number
- NCT01062620
- Sponsor
- Axelar AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2011-05-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.